Skip to main content
Top
Metadata
Title
Serum and plasma levels of FGF-2 and VEGF in healthy blood donors
Authors
A. Larsson
E. Sköldenberg
H. Ericson
Publication date
01-03-2002
Publisher
Kluwer Academic Publishers
Published in
Angiogenesis / Issue 1-2/2002
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1023/A:1021588227705

Other articles of this Issue 1-2/2002

Angiogenesis 1-2/2002 Go to the issue

Instructions for Authors

Instructions for authors

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine